Gene · 50484
Papers1,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of Hydroxyurea-Mediated DNA Damage Potentiation in Fanconi Anemia Cells. | Int J Mol Sci | 2026 | 42589438 | PubTator, text mining | PubMed |
| RRM2B is associated with low-level viremia during entecavir therapy in pediatric chronic hepatitis B and promotes profibrotic signaling in vitro. | Virol J | 2026 | 42436559 | PubTator, text mining | PubMed |
| Harmane induces apoptosis through RRM2B and suppresses colorectal cancer progression. | mSystems | 2026 | 42262096 | PubTator, text mining | PubMed |
| Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression. | J Neuroinflammation | 2026 | 42231304 | PubTator, text mining | PubMed |
| Microcavitary Alginate Hydrogel Reverses Chondrocyte Dedifferentiation via Temporal Modulation of the p53 Pathway. | Ann Biomed Eng | 2026 | 42098489 | PubTator, text mining | PubMed |
| Roles of RRM2 and RRM2B in pyrimidine stress responses and differentiation of acute myeloid leukemia cells. | Cell Death Discov | 2026 | 42031709 | PubTator, text mining | PubMed |
| Adaptive Regulation of dNTP Homeostasis Confers Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma. | Cancer Res | 2026 | 41941751 | PubTator, text mining | PubMed |
| Huntingtin (HTT) interactome in regulation of DNA repair/remodeling and RNA processing pathways. | Life Sci Alliance | 2026 | 41850723 | PubTator, text mining | PubMed |
| A Novel Truncating Pathogenic Variant in RRM2B in a Kurdish Family With Autosomal-Dominant Chronic Progressive External Ophthalmoplegia Plus (PEOA5). | J Clin Neuromuscul Dis | 2026 | 41766080 | PubTator, text mining | PubMed |
| Effect of a standardized meal on inflammatory biomarkers. | Scand J Clin Lab Invest | 2026 | 41689559 | PubTator, text mining | PubMed |
| Integrative clinico-molecular analysis reveals actionable subtypes and biomarkers in lung adenocarcinoma. | Cell Discov | 2026 | 41605901 | PubTator, text mining | PubMed |
| Acetylated Pyrimidine Metabolism Genes as Prognostic Markers and Their Influence on Immune Profiles in Lung Adenocarcinoma. | Hum Mutat | 2026 | 41584726 | PubTator, text mining | PubMed |
| NMR-based urinary biomarkers in pediatric primary mitochondrial disorders and chronic kidney disease: shared mitochondrial dysfunction, diverging biosignatures. | Metabolomics | 2026 | 41549148 | PubTator, text mining | PubMed |
| Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization. | Elife | 2025 | 41247789 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction in Sickle Cell Trait Carriers With Exertional Collapse. | Case Rep Genet | 2025 | 41098966 | PubTator, text mining | PubMed |
| Genetic dissection of Huntington's disease modification by variation at RRM2B. | Hum Mol Genet | 2025 | 41092345 | PubTator, text mining | PubMed |
| Lactylation-related gene signatures for prognosis and treatment response prediction in radiation-resistant non-small cell lung cancer. | Discov Oncol | 2025 | 41026305 | PubTator, text mining | PubMed |
| Didox, a ribonucleotide reductase inhibitor with iron chelator properties, counteracts the in vitro and in vivo growth of rhabdomyosarcoma cells. | Biochem Pharmacol | 2025 | 40925467 | PubTator, text mining | PubMed |
| Editorial: Rare diseases research and diagnosis in low- and middle-income countries. | Front Genet | 2025 | 40909438 | PubTator, text mining | PubMed |
| Blockade of de novo dNTP biosynthesis pathway delays HIV-1 early life cycle kinetics and dynamics. | mBio | 2025 | 40586616 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50484/papers